Acute severe asthma: Part 2. Current therapy.
Acute severe asthma is an extremely common and serious public health problem in the United States. Current optimum therapy of acute severe asthma includes supplemental oxygenation, nebulized beta-adrenergic receptor agonist therapy, and prompt use of glucocorticosteroids. In view of its low therapeutic index and the availability of more effective, less toxic agents, theophylline is no longer considered a first-line treatment. Ipratropium bromide combined with beta-agonist may augment bronchodilator responsiveness.
Garmon
R G
RG
Texas College of Osteopathic Medicine (TCOM), Fort Worth.
Zemenick
R B
RB
D000208:Acute Disease; D000336:Aerosols; D001249:Asthma / Q000188:drug therapy / Q000628:therapy*; D005260:Female; D006801:Humans; D009330:Nebulizers and Vaporizers; D010102:Oxygen Inhalation Therapy; D011247:Pregnancy; D012008:Recurrence
D000336:Aerosols